Piper Jaffray Initiates Coverage on Theravance (THRX) with an Overweight; Relovair $3bn+ Sales Excluding US Asthma
Tweet Send to a Friend
Piper Jaffray initiates coverage on Theravance Inc. (Nasdaq: THRX) with an Overweight rating.
Piper analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


